JP Morgan Chase’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-553
Closed -$6K 7349
2022
Q3
$6K Buy
+553
New +$5.5K ﹤0.01% 6078
2022
Q2
Sell
-369
Closed -$4K 7154
2022
Q1
$4K Hold
369
﹤0.01% 6366
2021
Q4
$4K Buy
+369
New +$3.62K ﹤0.01% 6453

Other funds holding HAAC

JP Morgan Chase's HAAC Position: Q4 2022 in Review

JP Morgan Chase sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 553 shares — an estimated $6K sold.

JP Morgan Chase first reported a position in HAAC in Q4 2021 and held it in 3 quarters. The position peaked at $6K in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

  • JP Morgan Chase reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 553 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6K.
  • JP Morgan Chase first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • JP Morgan Chase's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $6K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.